These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35057713)

  • 41. Motivational deficits and cognitive test performance in schizophrenia.
    Fervaha G; Zakzanis KK; Foussias G; Graff-Guerrero A; Agid O; Remington G
    JAMA Psychiatry; 2014 Sep; 71(9):1058-65. PubMed ID: 25075930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Redefining peripheral inflammation signature in schizophrenia based on the real-world FACE-SZ cohort.
    Fond G; Sunhary de Verville PL; Richieri R; Etchecopar-Etchart D; Korchia T; Faugere M; Godin O; Schürhoff F; Berna F; Aouizerate B; Capdevielle D; Chereau I; Clauss-Kobayashi J; Coulon N; Dorey JM; Dubertret C; Dubreucq J; Mallet J; Misdrahi D; Passerieux C; Pignon B; Rey R; Urbach M; Leboyer M;
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110335. PubMed ID: 33933539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Subjective quality of life in first episode schizophrenia spectrum disorders with comorbid depression.
    Sim K; Mahendran R; Siris SG; Heckers S; Chong SA
    Psychiatry Res; 2004 Dec; 129(2):141-7. PubMed ID: 15590041
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Major Depressive Disorder (MDD) and Schizophrenia- Addressing Unmet Needs With Partial Agonists at the D2 Receptor: A Review.
    Mallet J; Gorwood P; Le Strat Y; Dubertret C
    Int J Neuropsychopharmacol; 2019 Oct; 22(10):651-664. PubMed ID: 31406978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insight across mental disorders: A multifaceted metacognitive phenomenon.
    Konstantakopoulos G
    Psychiatriki; 2019; 30(1):13-16. PubMed ID: 31115349
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ten-Year Quality-of-Life Outcomes of Patients with Schizophrenia and Schizoaffective Disorders: The Relationship with Unmet Needs for Care.
    Ritsner MS; Grinshpoon A
    Clin Schizophr Relat Psychoses; 2015; 9(3):125-34A. PubMed ID: 23491971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risks of all-cause death and completed suicide in patients with schizophrenia/schizoaffective disorder treated with long-acting injectable or oral antipsychotics: A population-based retrospective cohort study in Taiwan.
    Tang CH; Shen SP; Huang MW; Qiu H; Watanabe S; Goh CH; Liu Y
    Eur Psychiatry; 2021 Dec; 65(1):e5. PubMed ID: 34895379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set.
    Fond G; Godin O; Brunel L; Aouizerate B; Berna F; Bulzacka E; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Strat Y; Micoulaud-Franchi JA; Misdrahi D; Rey R; Richieri R; Passerieux C; Schandrin A; Schürhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Leboyer M;
    J Affect Disord; 2016 Feb; 191():209-15. PubMed ID: 26674214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Learning potential and cognitive remediation in schizophrenia].
    Raffard S; Gely-Nargeot MC; Capdevielle D; Bayard S; Boulenger JP
    Encephale; 2009 Sep; 35(4):353-60. PubMed ID: 19748372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Experiences of victimisation and depression are associated with community functioning among men with schizophrenia.
    Hodgins S; Lincoln T; Mak T
    Soc Psychiatry Psychiatr Epidemiol; 2009 Jun; 44(6):448-57. PubMed ID: 19030767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Therapeutic benefit of a registered psychoeducation program on treatment adherence, objective and subjective quality of life: French pilot study for schizophrenia].
    Sauvanaud F; Kebir O; Vlasie M; Doste V; Amado I; Krebs MO
    Encephale; 2017 May; 43(3):235-240. PubMed ID: 27658989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circadian functioning and quality of life in substance use disorder patients with and without comorbid schizophrenia.
    Hashemzadeh I; Navarro JF; Adan A
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jan; 120():110623. PubMed ID: 36029929
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nicotine dependence is associated with depression and childhood trauma in smokers with schizophrenia: results from the FACE-SZ dataset.
    Rey R; D'Amato T; Boyer L; Brunel L; Aouizerate B; Berna F; Capdevielle D; Chereau I; Chesnoy-Servanin G; Denizot H; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Lancon C; Mallet J; Misdrahi D; Passerieux C; Schandrin A; Schürhoff F; Urbach M; Vidailhet P; Llorca PM; Fond G;
    Eur Arch Psychiatry Clin Neurosci; 2017 Sep; 267(6):567-577. PubMed ID: 28389889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional outcome and service engagement in major depressive disorder with psychotic features: comparisons with schizophrenia, schizoaffective disorder and bipolar disorder in a 6-year follow-up of the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS).
    Kingston T; Scully PJ; Browne DJ; Baldwin PA; Kinsella A; O'Callaghan E; Russell V; Waddington JL
    CNS Neurosci Ther; 2018 Jul; 24(7):633-640. PubMed ID: 29575682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allocating effort and anticipating pleasure in schizophrenia: Relationship with real world functioning.
    Serper M; Payne E; Dill C; Portillo C; Taliercio J
    Eur Psychiatry; 2017 Oct; 46():57-64. PubMed ID: 29031122
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immuno-metabolic profile of patients with psychotic disorders and metabolic syndrome. Results from the FACE-SZ cohort.
    Foiselle M; Barbosa S; Godin O; Wu CL; Boukouaci W; Andre M; Aouizerate B; Berna F; Barau C; Capdevielle D; Vidailhet P; Chereau I; Davidovic L; Dorey JM; Dubertret C; Dubreucq J; Faget C; Fond G; Leigner S; Llorca PM; Mallet J; Misdrahi D; Martinuzzi E; Passerieux C; Rey R; Pignon B; Urbach M; Schürhoff F; Glaichenhaus N; Leboyer M; Tamouza R;
    Brain Behav Immun Health; 2022 Jul; 22():100436. PubMed ID: 35469211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modifiable predictors of self-reported and performance-based functioning in individuals with schizophrenia-spectrum disorders and high levels of negative symptoms.
    Mahmood Z; Parrish EM; Keller AV; Lykins HC; Pickell D; Granholm E; Twamley EW
    J Psychiatr Res; 2022 Jul; 151():347-353. PubMed ID: 35533518
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses.
    Mucci A; Galderisi S; Gibertoni D; Rossi A; Rocca P; Bertolino A; Aguglia E; Amore M; Bellomo A; Biondi M; Blasi G; Brasso C; Bucci P; Carpiniello B; Cuomo A; Dell'Osso L; Giordano GM; Marchesi C; Monteleone P; Niolu C; Oldani L; Pettorruso M; Pompili M; Roncone R; Rossi R; Tenconi E; Vita A; Zeppegno P; Maj M;
    JAMA Psychiatry; 2021 May; 78(5):550-559. PubMed ID: 33566071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deficiencies in Theory of Mind in patients with schizophrenia, bipolar disorder, and major depressive disorder: A systematic review of secondary literature.
    van Neerven T; Bos DJ; van Haren NE
    Neurosci Biobehav Rev; 2021 Jan; 120():249-261. PubMed ID: 33246019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suicidality in middle aged and older patients with schizophrenia and depressive symptoms: relationship to functioning and Quality of Life.
    Kasckow J; Montross L; Golshan S; Mohamed S; Patterson T; Sollanzano E; Zisook S
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1223-8. PubMed ID: 17506025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.